Boston Trust Walden Corp Buys 7,327 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

• Boston Trust Walden Corp increased its stake in Mettler-Toledo International by 21.2%, acquiring an additional 7,327 shares, bringing its total holdings to 41,937 shares worth approximately $49.26 million.
• Wall Street analysts have raised target prices for Mettler-Toledo International, with Citigroup increasing its target from $1,400 to $1,600, indicating a positive outlook for the stock.
• The company reported $10.09 earnings per share for the last quarter, surpassing analysts' estimates, and set its FY 2025 guidance at EPS of 42.100-42.600.

Boston Trust Walden Corp raised its stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 21.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 41,937 shares of the medical instruments supplier's stock after acquiring an additional 7,327 shares during the quarter. Boston Trust Walden Corp owned about 0.20% of Mettler-Toledo International worth $49,264,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Greenleaf Trust increased its holdings in shares of Mettler-Toledo International by 1.2% during the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after purchasing an additional 10 shares during the period. Brooklyn Investment Group increased its holdings in shares of Mettler-Toledo International by 12.8% during the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier's stock worth $104,000 after purchasing an additional 10 shares during the period. Sax Wealth Advisors LLC increased its holdings in shares of Mettler-Toledo International by 2.8% during the second quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier's stock worth $437,000 after purchasing an additional 10 shares during the period. Sequoia Financial Advisors LLC increased its holdings in shares of Mettler-Toledo International by 1.8% during the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after purchasing an additional 11 shares during the period. Finally, Albion Financial Group UT increased its holdings in shares of Mettler-Toledo International by 1.5% during the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after purchasing an additional 11 shares during the period. 95.07% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the stock. Citigroup raised their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a report on Thursday, August 21st. Bank of America raised their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a "neutral" rating in a report on Monday, September 22nd. Weiss Ratings reiterated a "hold (c)" rating on shares of Mettler-Toledo International in a research report on Wednesday, October 8th. Barclays increased their price target on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an "overweight" rating in a research report on Thursday, October 2nd. Finally, Evercore ISI increased their price target on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 7th. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. According to data from MarketBeat, Mettler-Toledo International currently has an average rating of "Hold" and a consensus target price of $1,336.50.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,302.16 on Wednesday. The firm's fifty day moving average price is $1,281.30 and its two-hundred day moving average price is $1,191.57. The stock has a market cap of $26.82 billion, a PE ratio of 32.97, a PEG ratio of 3.86 and a beta of 1.37. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,486.76.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company's revenue was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, sell-side analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of the business's stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the sale, the director owned 283 shares of the company's stock, valued at approximately $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Shawn Vadala sold 300 shares of the business's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the sale, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,750,875. The trade was a 5.56% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,827 shares of company stock valued at $2,371,208. 0.77% of the stock is currently owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.